PermaWay 600 mg intramammary suspension for cattle
PermaWay 600 mg intramammary suspension for cattle
Authorised
- Cloxacillin hemibenzathine
Product identification
Medicine name:
PermaWay 600 mg intramammary suspension for cattle
PERMAWAY 600 mg intramamarna suspenzija za krave
Active substance:
- Cloxacillin hemibenzathine
Target species:
-
Cattle (dry cow)
Route of administration:
-
Intramammary use
Product details
Active substance and strength:
-
Cloxacillin hemibenzathine765.40/milligram(s)1.00Syringe
Pharmaceutical form:
-
Intramammary suspension
Withdrawal period by route of administration:
-
Intramammary use
-
Cattle (dry cow)
-
Meat and offal28day
-
Milkno withdrawal periodMilk: Interval between treatment and calving is 42 days or longer: 4 days after calving.Interval between treatment and calving is less than 42 days: 46 days after treatment
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ51CF02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Slovenia
Package description:
- box containing 96 intramammary syringes
- box containing 48 intramammary syringes
- box containing 24 intramammary syringes
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Hybrid application (Article 13(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Vetoquinol Biowet Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
- Vetoquinol Biowet Sp. z o.o.
Responsible authority:
- Agency For Medicinal Products And Medical Devices Of The Republic Of Slovenia
Authorisation number:
- DC/V/0720/001
Date of authorisation status change:
Reference member state:
-
Spain
Procedure number:
- ES/V/0384/001
Concerned member states:
-
Austria
-
Belgium
-
Cyprus
-
Czechia
-
Estonia
-
France
-
Germany
-
Greece
-
Hungary
-
Ireland
-
Italy
-
Latvia
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 22/12/2023
Slovenian (PDF)
Published on: 2/03/2022
Package Leaflet
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 2/03/2022
Labelling
This document does not exist in this language (English). You can find it
in another language below.
Slovenian (PDF)
Published on: 2/03/2022
Combined File of all Documents
English (PDF)
Download Published on: 24/07/2025